Back to Journals » OncoTargets and Therapy » Volume 11

Development and validation of a prognostic signature for preoperative prediction of overall survival in gastric cancer patients

Authors Zhu M, Wang Q, Luo Z, Liu K, Zhang Z

Received 28 July 2018

Accepted for publication 26 October 2018

Published 4 December 2018 Volume 2018:11 Pages 8711—8722

DOI https://doi.org/10.2147/OTT.S181741

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Amy Norman

Peer reviewer comments 3

Editor who approved publication: Dr Leo Jen-Liang Su


Minggu Zhu,1,* Qicai Wang,2,* Zhaowen Luo,1 Kelong Liu,2 Zhiqiao Zhang1

1Department of Internal Medicine, The Affiliated Chencun Hospital of Shunde Hospital, Southern Medical University, Shunde District, Guangdong, China; 2Department of General Surgery, The Affiliated Chencun Hospital of Shunde Hospital, Southern Medical University, Shunde District, Guangdong, China

*These authors contributed equally to this work

Background: As a serious challenge for public health, the prognosis of gastric cancer patients is still poor. The current study aimed to develop and validate a prognostic signature to predict the overall survival of gastric cancer patients.
Patients and methods: The dataset in the present study was obtained from The Cancer Genome Atlas database. The present study finally included 343 gastric cancer patients with information on long non-coding RNA (lncRNA) expression and overall survival.
Results: A prognostic model named Eleven-lncRNA signature was constructed according to the expression values of eleven prognostic lncRNA predictors identified by univariate and multivariate Cox regression model. According to time-dependent receiver operating characteristic curves, the Harrell’s concordance indexes of Eleven-lncRNA signature were 0.764 (95% CI 0.720–0.808), 0.776 (95% CI 0.732–0.820), and 0.807 (95% CI 0.763–0.851) for 1-year overall survival, 3-year overall survival, and 5-year overall survival respectively in the model group. In the validation group, the Harrell’s concordance indexes of Eleven-lncRNA signature were 0.748 (95% CI 0.704–0.792), 0.794 (95% CI 0.750–0.838), and 0.798 (95% CI 0.754–0.842) for 1-year overall survival, 3-year overall survival, and 5-year overall survival respectively. The gastric cancer patients (n=343) in the model group could be stratified into low-risk group (n=171) and high-risk group (n=172) according to the median of Eleven-lncRNA signature score. Kaplan–Meier survival curves showed that the mortality rate in the high-risk group was significantly poorer than that in the low-risk group (P<0.001).
Conclusion: The present study constructed and validated a prognostic model named Eleven-lncRNA signature for preoperative individual mortality risk prediction in gastric cancer patients. This Eleven-lncRNA signature can predict the individual mortality risk of gastric cancer patients and is helpful in improving clinical decision making regarding individualized treatment.

Keywords: long non-coding RNA, gastric cancer, overall survival, signature, prognosis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]